Showing results (21-30 of 178) with videos related to
Sort By:
Pageof 18
Brain Sciences|January 8, 2025
CAR-T Cells for the Treatment of Central Nervous System Tumours: Known and Emerging NeurotoxicitiesLeonardo Palazzo, Valentina Pieri, Giulia Berzero, et al.Critical Reviews in Oncology/Hematology|October 22, 2021
Gamma Knife radiosurgery as primary treatment of low-grade brainstem gliomas: A systematic review and metanalysis of current evidence and predictive factorsFilippo Gagliardi, Pierfrancesco De Domenico, Silvia Snider, et al.Neuro-Oncology Advances|February 23, 2024
Reassessing the efficacy of bevacizumab in newly diagnosed glioblastoma: A systematic review and external pseudodata-based analysisGiacomo Sferruzza, Massimo Malcangi, Luca Bosco, et al.Discovery Medicine|April 4, 2017
Hypermutations in gliomas: a potential immunotherapy targetGaetano Finocchiaro, Tiziana Langella, Cristina Corbetta, et al.Handbook of Clinical Neurology|March 8, 2016
Principles of immunotherapyBrandon D Liebelt, Gaetano Finocchiaro, Amy B HeimbergerExpert Review of Molecular Diagnostics|November 15, 2018
The clinical use of IDH1 and IDH2 mutations in gliomasAlberto Picca, Giulia Berzero, Anna Luisa Di Stefano, et al.Neuro-Oncology|June 28, 2025
Assessing time-trend bias in glioblastoma prognosis over two decades of clinical trialsGiacomo Sferruzza, Karthik Desingu, Andrés Cubero Cruz, et al.Oncoimmunology|November 20, 2012
Immunotherapy against the radial glia marker GLAST effectively triggers specific antitumor effectors without autoimmunityGabriele Cantini, Federica Pisati, Sara Pessina, et al.Neuroscience Letters|October 19, 2004
Expression of MATH1, a marker of cerebellar granule cell progenitors, identifies different medulloblastoma sub-typesEttore Salsano, Bianca Pollo, Marica Eoli, et al.Journal of Immunology Research|May 18, 2017
MRI in Glioma Immunotherapy: Evidence, Pitfalls, and PerspectivesDomenico Aquino, Andrea Gioppo, Gaetano Finocchiaro, et al.Pageof 18